Keith L Brownlie Insider Trading $SNGX SOLIGENIX, INC.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Keith L Brownlie.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Keith L Brownlie. Keith L Brownlie is Director in Celldex Therapeutics, Inc. ($AVAN) and Director in SOLIGENIX, INC. ($DOR) and Director in IMMUNE PHARMACEUTICALS INC ($IMNP) and Director in RXi Pharmaceuticals Corp ($RXII).

Keith L Brownlie in SOLIGENIX, INC.

Trading Symbol: SNGX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Keith L Brownlie: Director
Holdings: 50,000 shares
Latest Transaction: Sep 28 2018

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Keith L Brownlie in SOLIGENIX, INC.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, CLDX, IMNP, PHIO, SNGX

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Sep 28 2018	SNGX	SOLIGENIX, INC.	Brownlie Keith L	Director	Option Exercise	A	1.67	17,964	30,000	17,964
Jun 12 2017	DOR	SOLIGENIX, INC.	Brownlie Keith L	Director	Option Exercise	A	2.29	13,100	29,999	13,100
Jun 19 2015	DOR	SOLIGENIX, INC.	Brownlie Keith L	Director	Option Exercise	A	1.51	19,868	30,001	19,868
Apr 09 2015	DOR	SOLIGENIX, INC.	Brownlie Keith L	Director	Option Exercise	M	0.61	14,286	8,714	0
Apr 09 2015	DOR	SOLIGENIX, INC.	Brownlie Keith L	Director	Buy	M	0.61	14,286	8,714	50,000	35.7 K to 50 K (+40.00 %)

Page: 1